Skip to main content
. 2020 Feb 4;17(3):390–402. doi: 10.7150/ijms.39172

Table 3.

CI and dose reduction values for inhibition on A549, H1957 and PC9 by combining doxorubicin with apatinib

% Inhibition CI Doxorubicin Apatinib
Conc.:(μmol/L) Dose
reduction
Conc.:(μmol/L) Dose
reduction
Alone Mix Alone Mix
A549
50 0.8545 0.784 0.523 1.499 28.998 4.445 6.523
75 1.0332 1.245 0.971 1.282 39.449 8.162 4.833
95 0.9853 1.879 1.435 1.309 54.518 12.751 4.276
NCI-H1975
50 0.5675 0.872 0.231 3.775 13.193 1.242 10.622
75 0.6121 1.411 0.476 2.964 23.643 4.116 5.744
95 0.6798 1.942 0.712 2.728 39.532 5.532 7.146
PC9
50 1.1964 0.214 0.201 1.209 24.682 1.888 13.073
75 1.0532 0.387 0.329 1.294 38.784 2.843 13.641
95 1.1723 0.512 0.483 1.270 51.343 4.032 12.733